{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:00:58Z","timestamp":1794848458921,"version":"4.9.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H00231"],"award-info":[{"award-number":["JP20H00231"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioma is a primary brain tumor and the assessment of its molecular profile in a minimally invasive manner is important in determining treatment strategies. Among the molecular abnormalities of gliomas, mutations in the isocitrate dehydrogenase (IDH) gene are strong predictors of treatment sensitivity and prognosis. In this study, we attempted to non-invasively diagnose glioma development and the presence of IDH mutations using multivariate analysis of the plasma mid-infrared absorption spectra for a comprehensive and sensitive view of changes in blood components associated with the disease and genetic mutations. These component changes are discussed in terms of absorption wavenumbers that contribute to differentiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma samples were collected at our institutes from 84 patients with glioma (13 oligodendrogliomas, 17 IDH-mutant astrocytoma, 7 IDH wild-type diffuse glioma, and 47 glioblastomas) before treatment initiation and 72 healthy participants. FTIR-ATR spectra were obtained for each plasma sample, and PLS discriminant analysis was performed using the absorbance of each wavenumber in the fingerprint region of biomolecules as the explanatory variable. This data was used to distinguish patients with glioma from healthy participants and diagnose the presence of IDH mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The derived classification algorithm distinguished the patients with glioma from healthy participants with 83% accuracy (area under the curve (AUC) in receiver operating characteristic (ROC)\u2009=\u20090.908) and diagnosed the presence of IDH mutation with 75% accuracy (AUC\u2009=\u20090.752 in ROC) in cross-validation using 30% of the total test data. The characteristic changes in the absorption spectra suggest an increase in the ratio of \u03b2-sheet structures in the conformational composition of blood proteins of patients with glioma. Furthermore, these changes were more pronounced in patients with IDH-mutant gliomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The plasma infrared absorption spectra could be used to diagnose gliomas and the presence of IDH mutations in gliomas with a high degree of accuracy. The spectral shape of the protein absorption band showed that the ratio of \u03b2-sheet structures in blood proteins was significantly higher in patients with glioma than in healthy participants, and protein aggregation was a distinct feature in patients with glioma with IDH mutations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-024-11970-y","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T06:03:18Z","timestamp":1708063398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Distinguishing IDH mutation status in gliomas using FTIR-ATR spectra of peripheral blood plasma indicating clear traces of protein amyloid aggregation"],"prefix":"10.1186","volume":"24","author":[{"given":"Saiko","family":"Kino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiteru","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyasu","family":"Niizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"11970_CR1","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.3390\/cancers15112883","volume":"15","author":"G Solomou","year":"2023","unstructured":"Solomou G, Finch A, Asghar A, Bardella C. Mutant IDH in gliomas: Role in cancer and treatment options. Cancers. 2023;15:2883.","journal-title":"Cancers"},{"key":"11970_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41388-021-02056-1","volume":"41","author":"G Alzial","year":"2022","unstructured":"Alzial G, Renoult O, Paris F, Gratas C, Clavreul A, Pecqueur C. Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma. Oncogene. 2022;41:613\u201321.","journal-title":"Oncogene"},{"key":"11970_CR3","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","volume":"122","author":"S Han","year":"2020","unstructured":"Han S, Liu Y, Cai SJ, Qian M, Ding J, Larion M, et al. IDH mutation in glioma: molecular mechanisms and potential therapeutic targets. Br J Cancer. 2020;122:1580\u20139.","journal-title":"Br J Cancer"},{"key":"11970_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13578-017-0165-3","volume":"7","author":"H Al-Khallaf","year":"2017","unstructured":"Al-Khallaf H. Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight. Cell Biosci. 2017;7:37.","journal-title":"Cell Biosci"},{"issue":"5","key":"11970_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng.3273","volume":"47","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Aoki K, Chiba K, Sato Y, Shiozawa Y, Shiraishi Y, et al. Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet. 2015;47(5):458\u201368.","journal-title":"Nat Genet"},{"issue":"26","key":"11970_CR6","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, et al. Comprehensive, Integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372(26):2481\u201398.","journal-title":"N Engl J Med"},{"key":"11970_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nature08617","author":"L Dang","year":"2009","unstructured":"Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009. https:\/\/doi.org\/10.1038\/nature08617.","journal-title":"Nature"},{"issue":"5897","key":"11970_CR8","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807\u201312.","journal-title":"Science"},{"issue":"8","key":"11970_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u201351.","journal-title":"Neuro Oncol"},{"issue":"3","key":"11970_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11060-016-2201-2","volume":"129","author":"T Kawaguchi","year":"2016","unstructured":"Kawaguchi T, Sonoda Y, Shibahara I, Saito R, Kanamori M, Kumabe T, et al. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1\/2 mutation without the 1p\/19q co-deletion. J Neurooncol. 2016;129(3):505\u201314.","journal-title":"J Neurooncol"},{"issue":"1","key":"11970_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/2011.2.JNS10998","volume":"115","author":"N Sanai","year":"2011","unstructured":"Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115(1):3\u20138.","journal-title":"J Neurosurg"},{"issue":"4","key":"11970_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nm.2682","volume":"18","author":"C Choi","year":"2012","unstructured":"Choi C, Ganji SK, DeBerardinis RJ, Hatanpaa KJ, Rakheja D, Kovacs Z, et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med. 2012;18(4):624\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"11970_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3174\/ajnr.A6875","volume":"42","author":"AP Bhandari","year":"2021","unstructured":"Bhandari AP, Liong R, Koppen J, Murthy SV, Lasocki A. Noninvasive determination of IDH and 1p19q status of lower-grade gliomas using MRI radiomics: A systematic review. AJNR Am J Neuroradiol. 2021;42(1):94\u2013101.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"11970_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s10014-018-0317-0","volume":"35","author":"M Kanamori","year":"2018","unstructured":"Kanamori M, Maekawa M, Shibahara I, Saito R, Chonan M, Shimada M, et al. Rapid detection of mutation in isocitrate dehydrogenase 1 and 2 genes using mass spectrometry. Brain Tumor Pathol. 2018;35(2):90\u20136.","journal-title":"Brain Tumor Pathol"},{"issue":"Suppl 2","key":"11970_CR15","first-page":"ii66","volume":"4","author":"A Ray","year":"2022","unstructured":"Ray A, Vohra TK. Liquid biopsy\u2014from bench to bedside. Neurooncol Adv. 2022;4(Suppl 2):ii66\u201372.","journal-title":"Neurooncol Adv"},{"issue":"1","key":"11970_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12014-023-09400-5","volume":"20","author":"A Ghorbani","year":"2023","unstructured":"Ghorbani A, Avery LM, Sohaei D, Soosaipillai A, Richer M, Horbinski C, et al. Discovery of novel glioma serum biomarkers by proximity extension assay. Clin Proteom. 2023;20(1):12.","journal-title":"Clin Proteom"},{"issue":"5","key":"11970_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5306\/wjco.v13.i5.412","volume":"13","author":"M Goutnik","year":"2022","unstructured":"Goutnik M, Lucke-Wold B. Commentary: Evaluating potential glioma serum biomarkers, with future applications. World J Clin Oncol. 2022;13(5):412\u20136.","journal-title":"World J Clin Oncol"},{"issue":"1","key":"11970_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1055\/s-0040-1721166","volume":"12","author":"G Sharma","year":"2021","unstructured":"Sharma G, Jain SK, Sinha VD. Peripheral inflammatory blood markers in diagnosis of glioma and IDH status. J Neurosci Rural Pract. 2021;12(1):88\u201394.","journal-title":"J Neurosci Rural Pract"},{"key":"11970_CR19","doi-asserted-by":"publisher","first-page":"665235","DOI":"10.3389\/fonc.2021.665235","volume":"11","author":"H Ali","year":"2021","unstructured":"Ali H, Harting R, de Vries R, Ali M, Wurdinger T, Best MG. Blood-based biomarkers for glioma in the context of gliomagenesis: A systematic review. Front Oncol. 2021;11:665235.","journal-title":"Front Oncol"},{"issue":"12","key":"11970_CR20","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.3390\/cancers14122891","volume":"14","author":"S Cabezas-Camarero","year":"2022","unstructured":"Cabezas-Camarero S, Garc\u00eda-Barber\u00e1n V, P\u00e9rez-Alfayate R, Casado-Fari\u00f1as I, Sloane H, Jones FS, et al. Detection of IDH1 mutations in plasma using BEAMing technology in patients with gliomas. Cancers (Basel). 2022;14(12):2891.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"11970_CR21","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/ijc.34401","volume":"152","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zhang J, Hu X, Yin S, Yuan Y, Xia L, et al. Noninvasive detection of brain gliomas using plasma cell-free DNA 5-hydroxymethylcytosine sequencing. Int J Cancer. 2023;152(8):1707\u201318.","journal-title":"Int J Cancer"},{"issue":"31","key":"11970_CR22","doi-asserted-by":"publisher","first-page":"17060","DOI":"10.1002\/anie.202103272","volume":"60","author":"L Voronina","year":"2021","unstructured":"Voronina L, Leonardo C, Mueller-Reif JB, Geyer PE, Huber M, Trubetskov M, et al. Molecular origin of blood-based infrared spectroscopic ffingerprints*. Angew Chem Int Ed Engl. 2021;60(31):17060\u20139.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"6","key":"11970_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1177\/0003702820985856","volume":"75","author":"K Kochan","year":"2021","unstructured":"Kochan K, Bedolla DE, Perez-Guaita D, Adegoke JA,Chakkumpulakkal Puthan Veettil T, Martin M, et al. Infrared spectroscopy of blood. Appl Spectrosc. 2021;75(6):611\u201346.","journal-title":"Appl Spectrosc"},{"key":"11970_CR24","doi-asserted-by":"publisher","first-page":"e68758","DOI":"10.7554\/eLife.68758","volume":"10","author":"M Huber","year":"2021","unstructured":"Huber M, Kepesidis KV, Voronina L, Fleischmann F, Fill E, Hermann J, et al. Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer. Elife. 2021;10:e68758.","journal-title":"Elife"},{"key":"11970_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/cancers12010115","volume":"12","author":"KY Su","year":"2020","unstructured":"Su KY, Lee WL. Fourier transform infrared spectroscopy as a cancer screening and diagnostic tool: A review and prospects. Cancers. 2020;12:115.","journal-title":"Cancers"},{"issue":"10","key":"11970_CR26","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1021\/acs.analchem.6b04578","volume":"89","author":"S Roy","year":"2017","unstructured":"Roy S, Perez-Guaita D, Andrew DW, Richards JS, McNaughton D, Heraud P, et al. Simultaneous ATR-FTIR based determination of malaria parasitemia, glucose and urea in whole blood dried onto a glass slide. Anal Chem. 2017;89(10):5238\u201345.","journal-title":"Anal Chem"},{"key":"11970_CR27","doi-asserted-by":"publisher","first-page":"100001","DOI":"10.1016\/j.clispe.2020.100001","volume":"1","author":"S Roy","year":"2019","unstructured":"Roy S, Perez-Guaita D, Bowden S, Heraud P, Wood BR. Spectroscopy goes viral: Diagnosis of hepatitis B and C virus infection from human sera using ATR-FTIR spectroscopy. Clin Spectrosc. 2019;1:100001.","journal-title":"Clin Spectrosc"},{"issue":"8","key":"11970_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1089\/omi.2013.0157","volume":"18","author":"L Sitole","year":"2014","unstructured":"Sitole L, Steffens F, Kr\u00fcger TP, Meyer D. Mid-ATR-FTIR spectroscopic profiling of HIV\/AIDS sera for novel systems diagnostics in global health. OMICS. 2014;18(8):513\u201323.","journal-title":"OMICS"},{"key":"11970_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.saa.2013.11.049","volume":"122","author":"X Wang","year":"2014","unstructured":"Wang X, Shen X, Sheng D, Chen X, Liu X. FTIR spectroscopic comparison of serum from lung cancer patients and healthy persons. Spectrochim Acta A Mol Biomol Spectrosc. 2014;122:193\u20137.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"2","key":"11970_CR30","doi-asserted-by":"publisher","first-page":"e0279669","DOI":"10.1371\/journal.pone.0279669","volume":"18","author":"AG Theakstone","year":"2023","unstructured":"Theakstone AG, Brennan PM, Jenkinson MD, Goodacre R, Baker MJ. Investigating centrifugal filtration of serum-based FTIR spectroscopy for the stratification of brain tumours. PLoS ONE. 2023;18(2):e0279669.","journal-title":"PLoS ONE"},{"issue":"1","key":"11970_CR31","first-page":"vdac024","volume":"4","author":"JM Cameron","year":"2022","unstructured":"Cameron JM, Brennan PM, Antoniou G, Butler HJ, Christie L, Conn JJA, et al. Clinical validation of a spectroscopic liquid biopsy for earlier detection of brain cancer. Neurooncol Adv. 2022;4(1):vdac024.","journal-title":"Neurooncol Adv"},{"issue":"15","key":"11970_CR32","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.3390\/cancers13153851","volume":"13","author":"AG Theakstone","year":"2021","unstructured":"Theakstone AG, Brennan PM, Jenkinson MD, Mills SJ, Syed K, Rinaldi C, et al. Rapid spectroscopic liquid biopsy for the universal detection of brain tumours. Cancers. 2021;13(15):3851.","journal-title":"Cancers"},{"issue":"2","key":"11970_CR33","doi-asserted-by":"publisher","first-page":"fcab056","DOI":"10.1093\/braincomms\/fcab056","volume":"3","author":"PM Brennan","year":"2021","unstructured":"Brennan PM, Butler HJ, Christie L, Hegarty MG, Jenkinson MD, Keerie C, et al. Early diagnosis of brain tumors using a novel spectroscopic liquid biopsy. Brain Commun. 2021;3(2):fcab056.","journal-title":"Brain Commun"},{"issue":"22","key":"11970_CR34","doi-asserted-by":"publisher","first-page":"6736","DOI":"10.1039\/C9AN01731C","volume":"144","author":"JM Cameron","year":"2019","unstructured":"Cameron JM, Butler HJ, Smith BR, Hegarty MG, Jenkinson MD, Syed K, et al. Developing infrared spectroscopic detection for stratifying brain tumour patients: glioblastoma multiforme vs. lymphoma. Analyst. 2019;144(22):6736\u201350.","journal-title":"Analyst"},{"issue":"1","key":"11970_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12527-5","volume":"10","author":"HJ Butler","year":"2019","unstructured":"Butler HJ, Brennan PM, Cameron JM, Finlayson D, Hegarty MG, Jenkinson MD, et al. Development of high-throughput ATR-FTIR technology for rapid triage of brain cancer. Nat Commun. 2019;10(1):1\u20139.","journal-title":"Nat Commun"},{"key":"11970_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11060-016-2060-x","volume":"127","author":"JR Hands","year":"2016","unstructured":"Hands JR, Clemens G, Stables R, Ashton K, Brodbelt A, Davis C, et al. Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopy. J Neurooncol. 2016;127:463\u201372.","journal-title":"J Neurooncol"},{"key":"11970_CR37","doi-asserted-by":"publisher","first-page":"102308","DOI":"10.1016\/j.pdpdt.2021.102308","volume":"35","author":"F Chen","year":"2021","unstructured":"Chen F, Meng C, Qu H, Cheng C, Chen C, Yang B, et al. Human serum mid-infrared spectroscopy combined with machine learning algorithms for rapid detection of gliomas. Photodiagnosis Photodyn Ther. 2021;35:102308.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"12","key":"11970_CR38","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1039\/C5AN02452H","volume":"141","author":"BR Smith","year":"2016","unstructured":"Smith BR, Ashton KM, Brodbelt A, Dawson T, Jenkinson MD, Hunt NT, et al. Combining random forest and 2D correlation analysis to identify serum spectral signatures for neuro-oncology. Analyst. 2016;141(12):3668\u201378.","journal-title":"Analyst"},{"issue":"3\u20134","key":"11970_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jbio.201300149","volume":"7","author":"JR Hands","year":"2014","unstructured":"Hands JR, Dorling KM, Abel P, Ashton KM, Brodbelt A, Davis C, et al. Attenuated total reflection Fourier transform infrared (ATR-FTIR) spectral discrimination of brain tumour severity from serum samples. J Biophotonics. 2014;7(3\u20134):189\u201399.","journal-title":"J Biophotonics"},{"issue":"23","key":"11970_CR40","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1007\/s00216-013-7163-z","volume":"405","author":"JR Hands","year":"2013","unstructured":"Hands JR, Abel P, Ashton K, Dawson T, Davis C, Lea RW, et al. Investigating the rapid diagnosis of gliomas from serum samples using infrared spectroscopy and cytokine and angiogenesis factors. Anal Bioanal Chem. 2013;405(23):7347\u201355.","journal-title":"Anal Bioanal Chem"},{"key":"11970_CR41","doi-asserted-by":"publisher","first-page":"122353","DOI":"10.1016\/j.talanta.2021.122353","volume":"231","author":"Z Guleken","year":"2021","unstructured":"Guleken Z, Bulut H, G\u00fcltekin G\u0130, Ar\u0131kan S, Yayl\u0131m \u0130, Hakan MT, et al. Assessment of structural protein expression by FTIR and biochemical assays as biomarkers of metabolites response in gastric and colon cancer. Talanta. 2021;231:122353.","journal-title":"Talanta"},{"key":"11970_CR42","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3390\/biom12121815","volume":"12","author":"S Guo","year":"2022","unstructured":"Guo S, Wei G, Chen W, Lei C, Xu C, Guan Y, et al. Fast and deep diagnosis using blood-based ATR-FTIR spectroscopy for digestive tract cancers. Biomolecules. 2022;12:1815.","journal-title":"Biomolecules"},{"issue":"1","key":"11970_CR43","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1186\/s12885-021-09017-7","volume":"21","author":"KV Kepesidis","year":"2021","unstructured":"Kepesidis KV, Bozic-Iven M, Huber M, Abdel-Aziz N, Kullab S, Abdelwarith A, et al. Breast-cancer detection using blood-based infrared molecular fingerprints. BMC Cancer. 2021;21(1):1287.","journal-title":"BMC Cancer"},{"key":"11970_CR44","doi-asserted-by":"publisher","first-page":"103550","DOI":"10.1016\/j.pdpdt.2023.103550","volume":"42","author":"B To\u0142pa","year":"2023","unstructured":"To\u0142pa B, Depciuch J, Jakubczyk P, Paja W, Pancerz K, Wosiak A, et al. Fourier transform infrared spectroscopic marker of glioblastoma obtained from machine learning and changes in the spectra. Photodiagnosis Photodyn Ther. 2023;42:103550.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"11970_CR45","doi-asserted-by":"publisher","first-page":"120773","DOI":"10.1016\/j.saa.2021.120773","volume":"269","author":"N Iturrioz-Rodr\u00edguez","year":"2022","unstructured":"Iturrioz-Rodr\u00edguez N, De Pasquale D, Fiaschi P, Ciofani G. Discrimination of glioma patient-derived cells from healthy astrocytes by exploiting Raman spectroscopy. Spectrochim Acta A Mol Biomol Spectrosc. 2022;269:120773.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"5","key":"11970_CR46","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/cancers13051073","volume":"13","author":"M Riva","year":"2021","unstructured":"Riva M, Sciortino T, Secoli R, D\u2019Amico E, Moccia S, Fernandes B, et al. Glioma biopsies classification using Raman spectroscopy and machine learning models on fresh tissue samples. Cancers (Basel). 2021;13(5):1073.","journal-title":"Cancers (Basel)"},{"key":"11970_CR47","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.3390\/cancers13164196","volume":"13","author":"T Sciortino","year":"2021","unstructured":"Sciortino T, Secoli R, d\u2019Amico E, Moccia S, Conti Nibali M, Gay L, et al. Raman spectroscopy and machine learning for IDH genotyping of unprocessed glioma biopsies. Cancers. 2021;13:4196.","journal-title":"Cancers"},{"issue":"1","key":"11970_CR48","first-page":"vdz008","volume":"1","author":"LJ Livermore","year":"2019","unstructured":"Livermore LJ, Isabelle M, Bell IM, Scott C, Walsby-Tickle J, Gannon J, et al. Rapid intraoperative molecular genetic classification of gliomas using Raman spectroscopy. Neurooncol Adv. 2019;1(1):vdz008.","journal-title":"Neurooncol Adv"},{"issue":"11","key":"11970_CR49","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1158\/1078-0432.CCR-17-1795","volume":"24","author":"O Uckermann","year":"2018","unstructured":"Uckermann O, Juratli TA, Galli R, Conde M, Wiedemuth R, Krex D, et al. Optical analysis of glioma: Fourier-transform infrared spectroscopy reveals the IDH1 mutation status. Clin Cancer Res. 2018;24(11):2530\u20138.","journal-title":"Clin Cancer Res"},{"key":"11970_CR50","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.3390\/cancers12123682","volume":"12","author":"JM Cameron","year":"2020","unstructured":"Cameron JM, Conn JJA, Rinaldi C, Sala A, Brennan PM, Jenkinson MD, et al. Interrogation of IDH1 status in gliomas by Fourier transform infrared spectroscopy. Cancers (Basel). 2020;12:3682.","journal-title":"Cancers (Basel)"},{"key":"11970_CR51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12885-023-10588-w","volume":"23","author":"A Quesnel","year":"2023","unstructured":"Quesnel A, Coles N, Angione C, Dey P, Polvikoski TM, Outeiro TF, et al. Glycosylation spectral signatures for glioma grade discrimination using Raman spectroscopy. BMC Cancer. 2023;23:174.","journal-title":"BMC Cancer"},{"key":"11970_CR52","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/cem.785","volume":"17","author":"M Barker","year":"2003","unstructured":"Barker M, Rayens W. Partial least squares for discrimination. J Chemom. 2003;17:166\u201373.","journal-title":"J Chemom"},{"key":"11970_CR53","first-page":"627","volume":"4","author":"K Hajian-Tilaki","year":"2013","unstructured":"Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Casp J Intern Med. 2013;4:627\u201335.","journal-title":"Casp J Intern Med"},{"key":"11970_CR54","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12859-023-05383-0","volume":"24","author":"NR Anwardeen","year":"2023","unstructured":"Anwardeen NR, Diboun I, Mokrab Y, Althani AA, Elrayess MA. Statistical methods and resources for biomarker discovery using metabolomics. BMC Bioinform. 2023;24:250.","journal-title":"BMC Bioinform"},{"key":"11970_CR55","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1039\/C5CS00511F","volume":"45","author":"BR Wood","year":"2016","unstructured":"Wood BR. The importance of hydration and DNA conformation in interpreting infrared spectra of cells and tissues. Chem Soc Rev. 2016;45:1980\u201398.","journal-title":"Chem Soc Rev"},{"key":"11970_CR56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0924-2031(03)00053-5","volume":"32","author":"G Deleris","year":"2003","unstructured":"Deleris G, Petibois C. Applications of FT-IR spectrometry to plasma contents analysis and monitoring. Vib Spectrosc. 2003;32:129\u201336.","journal-title":"Vib Spectrosc"},{"key":"11970_CR57","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1634\/theoncologist.2014-0266","volume":"20","author":"G Lombardi","year":"2015","unstructured":"Lombardi G, Corona G, Bellu L, Della Puppa A, Pambuku A, Fiduccia P, et al. Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma. Oncologist. 2015;20:562\u20137.","journal-title":"Oncologist"},{"key":"11970_CR58","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00249-021-01507-7","volume":"50","author":"J De Meutter","year":"2021","unstructured":"De Meutter J, Goormaghtigh E. Amino acid side chain contribution to protein FTIR spectra: impact on secondary structure evaluation. Eur Biophys J. 2021;50:641\u201351.","journal-title":"Eur Biophys J"},{"key":"11970_CR59","doi-asserted-by":"publisher","first-page":"e0221563","DOI":"10.1371\/journal.pone.0221563","volume":"14","author":"B Pavliukeviciene","year":"2019","unstructured":"Pavliukeviciene B, Zentelyte A, Jankunec M, Valiuliene G, Talaikis M, Navakauskiene R, et al. Amyloid \u03b2 oligomers inhibit growth of human cancer cells. PLoS ONE. 2019;14:e0221563.","journal-title":"PLoS ONE"},{"key":"11970_CR60","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/febs.14058","volume":"284","author":"G Goldblatt","year":"2017","unstructured":"Goldblatt G, Cilenti L, Matos JO, Lee B, Ciaffone N, Wang QX, et al. Unmodified and pyroglutamylated amyloid \u03b2 peptides form hypertoxic hetero-oligomers of unique secondary structure. FEBS J. 2017;284:1355\u201369.","journal-title":"FEBS J"},{"key":"11970_CR61","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/j.bbamem.2013.04.012","volume":"1828","author":"R Sarroukh","year":"2013","unstructured":"Sarroukh R, Goormaghtigh E, Ruysschaert JM, Raussens V. ATR-FTIR: a \u201crejuvenated\u201d tool to investigate amyloid proteins. Biochim Biophys Acta. 2013;1828:2328\u201338.","journal-title":"Biochim Biophys Acta"},{"key":"11970_CR62","doi-asserted-by":"publisher","first-page":"14146","DOI":"10.1074\/jbc.RA118.002787","volume":"293","author":"T Matsubara","year":"2018","unstructured":"Matsubara T, Yasumori H, Ito K, Shimoaka T, Hasegawa T, Sato T. Amyloid-\u03b2 fibrils assembled on ganglioside-enriched membranes contain both parallel \u03b2-sheets and turns. J Biol Chem. 2018;293:14146\u201354.","journal-title":"J Biol Chem"},{"key":"11970_CR63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1039\/D0AN01545H","volume":"146","author":"J Waeytens","year":"2021","unstructured":"Waeytens J, Mathurin J, Deniset-Besseau A, Arluison V, Bousset L, Rezaei H, et al. Probing amyloid fibril secondary structures by infrared nanospectroscopy: experimental and theoretical considerations. Analyst. 2021;146:132\u201345.","journal-title":"Analyst"},{"key":"11970_CR64","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12640-016-9682-9","volume":"31","author":"WS Jin","year":"2017","unstructured":"Jin WS, Bu XL, Liu YH, Shen LL, Zhuang ZQ, Jiao SS, et al. Plasma amyloid-beta levels in patients with different types of cancer. Neurotox Res. 2017;31:283\u20138.","journal-title":"Neurotox Res"},{"key":"11970_CR65","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/cei.13493","volume":"202","author":"A Zayas-Santiago","year":"2022","unstructured":"Zayas-Santiago A, D\u00edaz-Garc\u00eda A, Nu\u00f1ez-Rodr\u00edguez R, Inyushin M. Accumulation of amyloid beta in human glioblastomas. Clin Exp Immunol. 2022;202:325\u201334.","journal-title":"Clin Exp Immunol"},{"key":"11970_CR66","doi-asserted-by":"publisher","first-page":"BSR20230489","DOI":"10.1042\/BSR20230489","volume":"43","author":"S Singh","year":"2023","unstructured":"Singh S, Joshi V, Upadhyay A. Amyloids and brain cancer: molecular linkages and crossovers. Biosci Rep. 2023;43:BSR20230489.","journal-title":"Biosci Rep"},{"key":"11970_CR67","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fncel.2015.00191","volume":"9","author":"ST Ferreira","year":"2015","unstructured":"Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG. Soluble amyloid-\u03b2 oligomers as synaptotoxins leading to cognitive impairment in Alzheimer\u2019s disease. Front Cell Neurosci. 2015;9:191.","journal-title":"Front Cell Neurosci"},{"key":"11970_CR68","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.4161\/auto.29647","volume":"10","author":"MH Cho","year":"2014","unstructured":"Cho MH, Cho K, Kang HJ, Jeon EY, Kim HS, Kwon HJ, et al. Autophagy in microglia degrades extracellular \u03b2-amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy. 2014;10:1761\u201375.","journal-title":"Autophagy"},{"key":"11970_CR69","doi-asserted-by":"publisher","first-page":"7717","DOI":"10.1073\/pnas.1203193109","volume":"109","author":"JC Stroud","year":"2012","unstructured":"Stroud JC, Liu C, Teng PK, Eisenberg D. Toxic fibrillar oligomers of amyloid-\u03b2 have cross-\u03b2 structure. Proc Natl Acad Sci USA. 2012;109:7717\u201322.","journal-title":"Proc Natl Acad Sci USA"},{"key":"11970_CR70","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3233\/JAD-2010-091207","volume":"21","author":"H Wang","year":"2010","unstructured":"Wang H, Ma J, Tan Y, Wang Z, Sheng C, Chen S, et al. Amyloid-beta1-42 induces reactive oxygen species-mediated autophagic cell death in U87 and SH-SY5Y cells. J Alzheimers Dis. 2010;21:597\u2013610.","journal-title":"J Alzheimers Dis"},{"key":"11970_CR71","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1042\/BJ20090379","volume":"421","author":"C Emilie","year":"2009","unstructured":"Emilie C, Rabia S, Shiori TK, Leonid B, Sylvie D, Yves FD, et al. Antiparallel \u03b2-sheet: a signature structure of the oligomeric amyloid \u03b2-peptide. Biochem J. 2009;421:415\u201323.","journal-title":"Biochem J"},{"key":"11970_CR72","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3390\/brainsci10110862","volume":"10","author":"S Papin","year":"2020","unstructured":"Papin S, Paganetti P. Emerging evidences for an Implication of the neurodegeneration-associated protein tau. Cancer Brain Sci. 2020;10:862.","journal-title":"Cancer Brain Sci"},{"issue":"527","key":"11970_CR73","doi-asserted-by":"publisher","first-page":"eaax1501","DOI":"10.1126\/scitranslmed.aax1501","volume":"12","author":"R Gargini","year":"2020","unstructured":"Gargini R, Segura-Collar B, Herr\u00e1nz B, Garc\u00eda-Escudero V, Romero-Bravo A, N\u00fa\u00f1ez FJ, et al. The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas. Sci Transl Med. 2020;12(527):eaax1501.","journal-title":"Sci Transl Med"},{"key":"11970_CR74","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrneurol.2017.162","volume":"14","author":"J Polanco","year":"2018","unstructured":"Polanco J, Li C, Bodea LG, Martinez-Marmol R, Meunier FA, G\u00f6tz J. Amyloid-\u03b2 and tau complexity \u2013 towards improved biomarkers and targeted therapies. Nat Rev Neurol. 2018;14:22\u201339.","journal-title":"Nat Rev Neurol"},{"key":"11970_CR75","doi-asserted-by":"publisher","first-page":"e2113641119","DOI":"10.1073\/pnas.2113641119","volume":"119","author":"E Guzman-Velez","year":"2022","unstructured":"Guzman-Velez E, Diez I, Schoemaker D, Pardilla-Delgado E, Vila-Castelar C, Fox-Fuller JT, et al. Amyloid-beta and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2022;119:e2113641119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"11970_CR76","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00401-020-02215-w","volume":"140","author":"N Korte","year":"2020","unstructured":"Korte N, Nortley R, Attwell D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer\u2019s disease. Acta Neuropathol. 2020;140:793\u2013810.","journal-title":"Acta Neuropathol"},{"key":"11970_CR77","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT. Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci. 2020;23:1183\u201393.","journal-title":"Nat Neurosci"},{"issue":"4","key":"11970_CR78","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-\u03b2 and tau: The trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71(4):505\u20138.","journal-title":"JAMA Neurol"},{"issue":"11","key":"11970_CR79","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/neuonc\/noac113","volume":"24","author":"JB Iorgulescu","year":"2022","unstructured":"Iorgulescu JB, Sun C, Neff C, Cioffi G, Gutierrez C, Kruchko C, et al. Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States. Neuro Oncol. 2022;24(11):1989\u20132000.","journal-title":"Neuro Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-11970-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-11970-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-11970-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T09:04:51Z","timestamp":1708333491000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-11970-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11970"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-11970-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3704757\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Tohoku University School of Medicine (Ethics Committee No. 2023\u20131-321). All plasma samples were collected in the University Hospital after obtaining written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"222"}}